回盛生物
(300871)
| 流通市值：41.68亿 | | | 总市值：41.68亿 |
| 流通股本：2.02亿 | | | 总股本：2.02亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 271,699,911.85 | 326,144,663.23 | 237,278,933.04 | 350,799,820.21 |
| 应收票据及应收账款 | 457,004,466.25 | 430,153,031.26 | 383,312,881.09 | 334,106,185.37 |
| 其中：应收票据 | 41,957,386.1 | 61,785,555.46 | 32,855,877.05 | 17,328,911.85 |
| 应收账款 | 415,047,080.15 | 368,367,475.8 | 350,457,004.04 | 316,777,273.52 |
| 应收款项融资 | 17,736,482.31 | 16,115,591.14 | 34,266,616.14 | 19,474,555.59 |
| 预付款项 | 31,383,544.9 | 71,014,168.55 | 58,465,173.64 | 22,178,782.34 |
| 其他应收款合计 | 11,487,346.9 | 8,087,668.77 | 3,770,892.04 | 3,456,205.39 |
| 存货 | 244,328,189.32 | 248,164,158.72 | 251,244,479.5 | 288,951,021.72 |
| 其他流动资产 | 14,409,257.95 | 11,940,519.63 | 8,664,203.32 | 10,795,947.57 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,346,009,223.51 | 1,312,585,417.22 | 1,209,306,834.79 | 1,235,017,572.57 |
| 非流动资产: | | | | |
| 投资性房地产 | 11,290,219.97 | 11,483,231.64 | 10,641,233.25 | 10,815,637.67 |
| 固定资产 | 1,505,027,290.5 | 1,525,198,068.46 | 1,522,390,094.03 | 1,490,728,306.5 |
| 在建工程 | 39,754,942.11 | 18,145,020.03 | 25,442,016.66 | 56,066,094.92 |
| 无形资产 | 113,541,296.23 | 114,441,743.87 | 113,725,190.21 | 114,161,871.78 |
| 长期待摊费用 | 1,732,421.77 | 1,898,710.71 | 2,064,999.71 | 2,231,288.72 |
| 递延所得税资产 | 25,045,333.41 | 27,168,464.42 | 25,544,475.65 | 24,670,320.47 |
| 其他非流动资产 | 3,749,048.58 | 3,762,208.67 | 3,418,474.64 | 7,379,466.53 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,700,140,552.57 | 1,702,097,447.8 | 1,703,226,484.15 | 1,706,052,986.59 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,046,149,776.08 | 3,014,682,865.02 | 2,912,533,318.94 | 2,941,070,559.16 |
| 流动负债: | | | | |
| 短期借款 | 355,689,151 | 316,784,375.11 | 370,179,161 | 339,021,054 |
| 应付票据及应付账款 | 450,632,356.35 | 507,302,745.13 | 432,575,726.49 | 369,125,433.62 |
| 其中：应付票据 | 226,488,758.46 | 283,877,725.77 | 207,962,025.84 | 146,954,674.91 |
| 应付账款 | 224,143,597.89 | 223,425,019.36 | 224,613,700.65 | 222,170,758.71 |
| 预收款项 | - | 10,200 | - | - |
| 合同负债 | 15,520,434.9 | 13,463,235.54 | 16,723,287.58 | 14,254,484.35 |
| 应付职工薪酬 | 13,792,846.63 | 20,259,817.66 | 18,062,279.26 | 14,288,194.95 |
| 应交税费 | 9,545,304.92 | 2,820,565.6 | 4,200,346.19 | 3,033,310.17 |
| 其他应付款合计 | 21,974,097.82 | 21,835,179.44 | 25,260,230.97 | 18,484,682.3 |
| 一年内到期的非流动负债 | 46,012,507.03 | 16,317,355.62 | 14,352,321.49 | 13,758,348.33 |
| 其他流动负债 | 34,927,318.21 | 24,521,628.73 | 11,772,719.49 | 9,568,431.68 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 948,094,016.86 | 923,315,102.83 | 893,126,072.47 | 781,533,939.4 |
| 非流动负债: | | | | |
| 长期借款 | 17,972,694 | 59,062,791.67 | 35,000,000 | 40,000,000 |
| 应付债券 | 428,386,493.14 | 496,391,884.2 | 492,025,133.3 | 616,743,192.86 |
| 递延收益 | 56,549,181.88 | 58,343,612.83 | 60,148,965.14 | 61,958,484.12 |
| 递延所得税负债 | 9,118,843.69 | 11,366,356.63 | 7,973,682.59 | 9,953,619.78 |
| 其他非流动负债 | 1,000,000 | 1,000,000 | 845,000 | 845,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 513,027,212.71 | 626,164,645.33 | 595,992,781.03 | 729,500,296.76 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,461,121,229.57 | 1,549,479,748.16 | 1,489,118,853.5 | 1,511,034,236.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 171,146,882 | 165,765,635 | 165,765,503 | 165,764,170 |
| 其他权益工具 | 85,377,429.15 | 100,013,662.44 | 102,470,647.95 | 126,903,438.43 |
| 资本公积 | 966,822,369.81 | 880,629,959.53 | 869,930,047.93 | 855,959,679.99 |
| 减:库存股 | 18,141,290.28 | 17,571,722.28 | 17,404,202.28 | 15,775,070.28 |
| 其他综合收益 | -1,662,134.21 | -1,474,241.12 | -785,663.87 | -1,605,959.83 |
| 盈余公积 | 52,979,506 | 52,979,506 | 52,979,506 | 52,979,506 |
| 未分配利润 | 321,730,983.86 | 277,234,024.45 | 249,731,309.85 | 245,510,934.65 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,578,253,746.33 | 1,457,576,824.02 | 1,422,687,148.58 | 1,429,736,698.96 |
| 少数股东权益 | 6,774,800.18 | 7,626,292.84 | 727,316.86 | 299,624.04 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,585,028,546.51 | 1,465,203,116.86 | 1,423,414,465.44 | 1,430,036,323 |
| 负债和股东权益合计 | 3,046,149,776.08 | 3,014,682,865.02 | 2,912,533,318.94 | 2,941,070,559.16 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |